1919 Investment Counsel’s Novo Nordisk NVO Stock Holding History

1919 Investment Counsel’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$20M	Buy	838,222 +71,834	+9%	+$1.65M	0.41%	71
2014 Q2	$17.7M	Buy	766,388 +48,560	+7%	+$1.07M	0.36%	76
2014 Q1	$16.4M	Buy	717,828 +80,438	+13%	+$1.71M	0.34%	77
2013 Q4	$11.8M	Buy	637,390 +155,970	+32%	+$2.72M	0.25%	91
2013 Q3	$8.15M	Buy	481,420 +4,770	+1%	+$80.2K	0.18%	112
2013 Q2	$7.39M	Buy	+476,650	New	+$7.93M	0.17%	118

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

1919 Investment Counsel's NVO Position: Q3 2014 in Review

1919 Investment Counsel increased its Novo Nordisk (NVO) stake by 9.4% in Q3 2014, buying an estimated $1.65M and bringing the position to 838,222 shares worth $20M. The position accounts for 0.41% of the portfolio, ranked #71.

1919 Investment Counsel first reported a position in NVO in Q2 2013 and has held it in 6 quarters since. 470 funds tracked by Wall St. Rank hold NVO as of Q3 2014.

1919 Investment Counsel held 838,222 shares of Novo Nordisk worth $20M as of Q3 2014.
1919 Investment Counsel bought 71,834 Novo Nordisk shares in Q3 2014, an estimated $1.65M.
Novo Nordisk made up 0.41% of 1919 Investment Counsel's portfolio in Q3 2014, its #71 holding.
1919 Investment Counsel first reported a position in Novo Nordisk in Q2 2013 and has held it in 6 quarters since.
470 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.